Evidence map›Paper›PMID 41125950›Full record

ArticleLangenbeck's archives of surgery2025

Stage-dependent survival in gastric cancer: a Danish nationwide cohort study.

Oliver Nørholm Kempf, Lise Bech Jellesmark Thorsen, Nikolaj Nerup, Daniel W Kjær, Jonas Sanberg, Mette Siemsen, Sarunas Dikinis, Michael Stenger, Rajendra Singh Garbyal, Lene Bæksgaard and 1 more

Abstract read
In one paragraph

Article in Langenbeck's archives of surgery, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 4 papers, 1 of them a synthesis that pooled it.

0numbers the graph read from it
0cells of the map it votes in
4citing papers in PubMed, 1 pooled it
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

4 citing papers in PubMed, 1 synthesis or guideline pooled it.

  1. Pooled it
  2. Article
  3. Longitudinal trajectories of nutritional markers in patients with de novo Stage IV gastric cancer: a descriptive analysis using one-year survival as a reference.Supportive care in cancer : official journal of the Multinational Association of Supportive Care in Cancer · 2026
    Article
  4. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

11 authors.

Oliver Nørholm KempfDepartment of Transplantation and Digestive Diseases, Copenhagen University Hospital Rigshospitalet, Inge Lehmanns Vej 7, 2100, Copenhagen, Denmark. Oliver.noerholm.kempf.01@regionh.dk.
Lise Bech Jellesmark ThorsenDepartment of Oncology, Aarhus University Hospital, Aarhus, Denmark.
Nikolaj NerupDepartment of Transplantation and Digestive Diseases, Copenhagen University Hospital Rigshospitalet, Inge Lehmanns Vej 7, 2100, Copenhagen, Denmark.
Daniel W KjærDepartment of Surgery, Aarhus University Hospital, Aarhus, Denmark.
Jonas SanbergDepartment of Surgery, Odense University Hospital, Odense, Denmark.
Mette SiemsenDepartment of Cardiothoracic Surgery, Copenhagen University Hospital Rigshospitalet, Copenhagen, Denmark.
Sarunas DikinisDepartment of Gastrointestinal Surgery, Aalborg University Hospital, Aalborg, Denmark.
Michael StengerDepartment of Cardiothoracic and Vascular Surgery, Odense University Hospital, Odense, Denmark.
Rajendra Singh GarbyalDepartment of Pathology, Copenhagen University Hospital Rigshospitalet, Copenhagen, Denmark.
Lene BæksgaardDepartment of Oncology, Copenhagen University Hospital Rigshospitalet, Copenhagen, Denmark.
Michael Patrick AchiamDepartment of Transplantation and Digestive Diseases, Copenhagen University Hospital Rigshospitalet, Inge Lehmanns Vej 7, 2100, Copenhagen, Denmark.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

backgroundGastric cancer remains a major clinical challenge with poor prognosis. This study investigated survival outcomes based on treatment strategy, tumor stage, and histology in Danish gastric cancer patients.

methodsFrom January 2013 to December 2021, 2,156 gastric cancers were registered in the Danish Esophagogastric Cancer Group database, covering 99% of national cases. Data were analyzed for patients with intestinal and diffuse-type cancers. Survival was assessed using Kaplan-Meier curves and Cox regression, adjusting for tumor stage, treatment, and demographics.

resultsMedian survival was significantly higher with surgery ± perioperative chemotherapy (SCT) than with palliative treatment. For the intestinal-type cancers, SCT resulted in a median survival of 45.2 months (95% CI [35.4-55.1]) versus 5.1 months (95% CI [4.6-5.7]) with palliative treatment. Patients with diffuse type, treated with SCT had a median survival exceeding 128 months, compared with 6.3 months (95% CI [5.2-7.5]) with palliative treatment. Patients receiving epirubicin based CT had a lower risk of death (HR 0.74, p = 0.04) compared with upfront surgery, while FLOT (5-fluorouracil, leucovorin, oxaliplatin, and docetaxel) similarly reduced the risk of death (HR 0.69, p = 0.04). No significant difference was observed between the two CT regimens. Palliative CT and radiotherapy improved survival over best supportive care (p < 0.001). Advanced tumor stage was associated with worse survival, while the histological subtype had no impact on overall survival outcomes.

conclusionThis study emphasizes the survival benefit of multimodal treatment strategies, especially surgery combined with perioperative CT. Palliative interventions also improved outcomes in advanced disease.

Indexed as

Stomach NeoplasmsAdultAgedAged, 80 and overAntineoplastic Combined Chemotherapy ProtocolsCohort StudiesDenmarkFemaleGastrectomyHumansMaleMiddle AgedNeoplasm StagingPalliative CareRegistriesSurvival RateCancer stageChemotherapyGastric cancer survivalSurgery

Identifiers

PMID41125950
PMCPMC12546399

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.